Positive thoughts attract positive vibes
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
LFG!
The float is so small
Thanks, I will look.
Can you guys let me know before it goes +400% lol
Sooner was correct! one day lol...
A little surprised with the sp, they must be parking orders in the darkpool again. Especially with this much volume.
The volume on April $12 strike was pretty heavy, half a million dollars worth of calls.
That was a quick move up! Was busy today and just seen it.
Thanks for finding and posting this article. Highlights why sales has a slower growth. Really is a specialty drug that takes proper diagnosis.
Was looking at COSM on the fintel website. I have no idea how they settled all the FTD's and covered all the short positions.
It's better that it is announced now then later. If they announce this after FDA approval it would kill the momentum. By doing this prior, they can sell into the run. The more cash the company has the better.
$1 billion is the magic number for blockbuster status. A big pharma would take it out if they know that is possible.
Added some today. I'll add up to 1% of my portfolio here for this play.
If Xphozah is approved and priced similar to Ibsrela. Imagine just 10% market penetration of 750,000 patients.
Ibsrela (tenapanor) is a member of the NHE3 inhibitors drug class and is commonly used for Irritable Bowel Syndrome with Constipation. The cost for Ibsrela oral tablet 50 mg is around $1,715 for a supply of 60 tablets, depending on the pharmacy you visit.
...
Oral Tablet.
Quantity Per unit Price
60 $28.59 $1,715.36
If approved, XPHOZAH will be the first and only phosphate absorption inhibitor, reducing serum phosphorus with one pill taken twice daily
For new investors, this old article has good info on why stock is rising. 11/17/22
https://ir.ardelyx.com/news-releases/news-release-details/ardelyx-announces-fda-advisory-committee-votes-benefits-xphozahr
Looking forward to exercising options on Friday.
Nice move up today!
Well said and I agree. A BP can easily lower price a little and have insurers all on board, they have greater political influence on them.
Adding to your message for others with a link.
CNI's have been around for a while, what makes Lupkynis (Voclosporin) better is it is a new more potent and less toxic CNI that can be taken orally. It probably can replace other CNI's if the research is done.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8584552/
Would be great if they could PR the terms of settlement. Will they get a little piece of Cequa in the form of royalties.
There is no way it trades flat with this much volume. Retail orders are being "parked" in the darkpool. That is the only way to pin the price like this.
Great way to start the year! I finally have lots in the Green.
Nice close going into the weekend.
Ahh that makes sense. They manipulated the crash post split and got out cheap.
No options, puts would be easy money and safe play.
How can float be 5.5M and short be 5.6M
https://fintel.io/ss/us/cosm
$3,000,000,000 wiped off market cap in a little over a year. How do you address that in 2023 AGM, maybe postpone to 2024 lol.
CEO definitely has more skin in the game than anyone else
6 month chart looks so beautiful with upcoming catalyst from FDA either next week or start the New Year off with a bang!
Actually it leaves more questions than answers. Need two opinions: scientist to say how similar or dissimilar it is and patent attorney opinion on how similarities infringe on AUPH patent. Both of which I'm sure AUPH had done or they would not have filed suit.
AUPH Patent 2008
https://patents.google.com/patent/US20090092665A1/en
Sun Pharma Patent 2017
https://patents.google.com/patent/US10918694B2/en
LFG!
Had some time to look into Dry Eye. Its very twisted. Suns patent looks more detailed as Auven went through phases of testing before selling to Sun. AUPH started there phases after.
(2014) AUPH has a dry eye patent from purchasing Lux Bioscience
https://patents.google.com/patent/US20090092665A1/en
(2009)Ashim Mitra worked with Lux Bioscience
LX214, developed in cooperation with Ashim Mitra, Ph.D., University of Missouri Curator’s Professor of Pharmacy and Director of Translational Research at UMKC School of Medicine School of Pharmacy, University of Missouri-Kansas City, is a proprietary formulation of Lux Biosciences’ next generation calcineurin inhibitor, voclosporin
https://www.ophthalmologyweb.com/1315-News/32734-Lux-Biosciences-Reports-Phase-1-Safety-Results-And-Open-Label-Efficacy-Results-For-LX214-A-Potential-Best-In-Class-Treatment-For-Dry-Eye/
(2014)Looks like Ashim shared the data with Auven Therapeutics which conducted their own phases
https://www.fiercebiotech.com/biotech/auven-therapeutics-announces-positive-results-from-pivotal-clinical-trial-of-seciera-otx
(2016)This is how Sun got the formula for Cequa
Auven Therapeutics Announces Sale of Ocular Technologies to Sun Pharma.
https://www.globenewswire.com/news-release/2016/10/26/883163/0/en/Auven-Therapeutics-Announces-Sale-of-Ocular-Technologies-to-Sun-Pharma.html
(2017) Sun files patent.
https://patents.google.com/patent/US10918694B2/en
Then another lawsuit from University and Undergrad student at the time. This was settled.
A Missouri graduate who said his professor (Ashim Mitra) stole his invention for a drug delivery system will share in its profits under a settlement that also gives the University of Missouri System a cut of the revenue
https://www.seattletimes.com/business/missouri-graduate-to-share-in-invention-profits-under-deal/
Looks like good news coming. The leak before announced.
This post caused a 10% increase in share price lol
No one knows if this will squeeze again or not. All we know is this is trading with volume over 5x the float. Fintel data which might be accurate or not shows short interest is pretty damn high. The volume and Fintel data suggest the price we are shown is incorrect and manipulated. I'm holding a position in which $0 is okay with me. I'd rather get a piece of the action than sit on the sideline if it rips higher. Good luck guys.
https://fintel.io/ss/us/cosm
Brand new CUSIP already with millions of IOU's. Crime committed daily with no enforcement.
Volume over 5x float, and we are here. this should be over $40
Its so sick bro. Everyone paid off to look the other way.
Rigged to the max. Interesting video, its a little long about 30 minutes. But shows how retail gets the short end. I'm not sure how much is true but it is definitely on the right path.